Pages that link to "Q24683764"
Jump to navigation
Jump to search
The following pages link to Mechanisms of action of glucagon-like peptide 1 in the pancreas (Q24683764):
Displaying 50 items.
- Structure-guided design of selective Epac1 and Epac2 agonists (Q21145700) (← links)
- Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function (Q24318496) (← links)
- Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease (Q24647189) (← links)
- Multiple Factors Related to the Secretion of Glucagon-Like Peptide-1 (Q26781127) (← links)
- Bile acids: emerging role in management of liver diseases (Q26796318) (← links)
- Exploiting the Pleiotropic Antioxidant Effects of Established Drugs in Cardiovascular Disease (Q26801173) (← links)
- Obestatin: a new metabolic player in the pancreas and white adipose tissue (Q26824623) (← links)
- GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence (Q26858990) (← links)
- Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis (Q27012696) (← links)
- DPP-4 inhibition and islet function (Q27028127) (← links)
- Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review (Q28079191) (← links)
- Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide (Q28081671) (← links)
- Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling (Q28084873) (← links)
- Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor (Q28484498) (← links)
- GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells (Q28506327) (← links)
- TLQP-21 protects human umbilical vein endothelial cells against high-glucose-induced apoptosis by increasing G6PD expression (Q28535350) (← links)
- The imaging of insulinomas using a radionuclide-labelled molecule of the GLP-1 analogue liraglutide: a new application of liraglutide (Q28538567) (← links)
- Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice (Q28546996) (← links)
- Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation (Q28551517) (← links)
- Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2 (Q28575947) (← links)
- Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells (Q30039774) (← links)
- Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection. (Q30390165) (← links)
- Impaired barrier function by dietary fructo-oligosaccharides (FOS) in rats is accompanied by increased colonic mitochondrial gene expression (Q33326016) (← links)
- G protein coupled receptors in embryonic stem cells: a role for Gs-alpha signaling (Q33531731) (← links)
- Glucose-dependent insulinotropic polypeptide signaling in pancreatic β-cells and adipocytes (Q33609770) (← links)
- Obestatin stimulates glucose-induced insulin secretion through ghrelin receptor GHS-R. (Q33681282) (← links)
- Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program (Q33732598) (← links)
- GLP-1 for type 2 diabetes (Q33794098) (← links)
- Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial. (Q33834266) (← links)
- Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor (Q33994409) (← links)
- How pancreatic beta-cells discriminate long and short timescale cAMP signals (Q33999602) (← links)
- Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide (Q34133324) (← links)
- Early life nutrition and metabolic programming (Q34149218) (← links)
- Evidence that Ca2+ within the microdomain of the L-type voltage gated Ca2+ channel activates ERK in MIN6 cells in response to glucagon-like peptide-1. (Q34193626) (← links)
- Exendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3β activity (Q34255639) (← links)
- Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium (Q34355984) (← links)
- Cyclic AMP sensor EPAC proteins and energy homeostasis (Q34385094) (← links)
- Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation (Q34405101) (← links)
- Polymorphism rs11085226 in the gene encoding polypyrimidine tract-binding protein 1 negatively affects glucose-stimulated insulin secretion (Q34450307) (← links)
- Lixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes--a study in both people with type 2 diabetes and healthy subjects (Q34543003) (← links)
- Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health (Q34589695) (← links)
- Emerging role of GLP-1 receptor agonists in the treatment of obesity (Q34620465) (← links)
- Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: therapeutic implications (Q34625376) (← links)
- Snapin mediates incretin action and augments glucose-dependent insulin secretion (Q34648996) (← links)
- Pharmacokinetic and pharmacodynamic modeling of exendin-4 in type 2 diabetic Goto-Kakizaki rats (Q34702329) (← links)
- Synthetic (+)-antroquinonol exhibits dual actions against insulin resistance by triggering AMP kinase and inhibiting dipeptidyl peptidase IV activities (Q34795679) (← links)
- DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets (Q34859889) (← links)
- The role of incretins in glucose homeostasis and diabetes treatment (Q34901533) (← links)
- A novel humanized GLP-1 receptor model enables both affinity purification and Cre-LoxP deletion of the receptor (Q35138670) (← links)
- Chronic hyperglycemia downregulates GLP-1 receptor signaling in pancreatic β-cells via protein kinase A (Q35163101) (← links)